search
  • Country
    Clear
  • Type
  • Compatibility Level
  • Thematic
  • Jurisdiction
2,169 Data sources

  • NL
  • IN

  • more_vert
  • more_vert
  • more_vert
  • more_vert
  • Open Government Data Portal of Tamil Nadu is a platform for supporting Open Data initiative of Government of Tamil Nadu. The portal is intended to be used by Departments/Organizations of Government of Tamil Nadu to publish datasets, documents, services, tools and applications collected by them for public use. It intends to increase transparency in the functioning of the state Government and also open avenues for many more innovative uses of Government Data to give different perspective.

    more_vert
  • more_vert
  • more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • chevron_left
  • 1
  • 2
  • 3
  • 4
  • 5
  • chevron_right
2,169 Data sources
  • more_vert
  • more_vert
  • more_vert
  • more_vert
  • Open Government Data Portal of Tamil Nadu is a platform for supporting Open Data initiative of Government of Tamil Nadu. The portal is intended to be used by Departments/Organizations of Government of Tamil Nadu to publish datasets, documents, services, tools and applications collected by them for public use. It intends to increase transparency in the functioning of the state Government and also open avenues for many more innovative uses of Government Data to give different perspective.

    more_vert
  • more_vert
  • more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • chevron_left
  • 1
  • 2
  • 3
  • 4
  • 5
  • chevron_right